Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 5—May 2011

Seroprevalence of Toscana Virus in Blood Donors, France, 2007

Nadège BrisbarreComments to Author , Houssam Attoui, Pierre Gallian, Paola Di Bonito, Colomba Giorgi, Jean-Francois Cantaloube, Philippe Biagini, Mhammed Touinssi, Francois Jordier, and Philippe de Micco
Author affiliations: Author affiliations: Université de la Méditerranée, Marseille, France (N. Brisbarre, P. Gallian, J.-F. Cantaloube, P. Biagini, M. Touinssi, F. Jordier, P. de Micco); Institute for Animal Health, Woking, UK (H. Attoui); Instituto Superiore di Sanità, Rome, Italy (P. Di Bonito, C. Giorgi)

Main Article


Prevalence of antibodies against Toscana virus in blood donors, France, 2007*

Demographic characteristic No. donors % IgG-positive samples % IgM-positive samples
Age, y
<30 211 11.8 3.8
30–39 133 11.3 3
40–49 156 11.5 2.6
50–60 158 10.8 4.4
F 353 13.9 2.5
French territorial division†
Alpes de Haute Provence 29 10.3 3.4
Hautes Alpes 64 6.25 1.6
Alpes Maritime 111 19 0
Bouches du Rhône 143 12.6 2.8
Corsica 115 8.7 8.7
Var 154 8.4 1.9
Total 729 11.5 3.3

*Plasma samples were determined as positive by using an ELISA to detect immunoglobulin (Ig) G against Toscana virus (absorbance cutoff value [optical density at 450 nm (OD450)]>0.47) and IgM (absorbance cutoff value of OD450>0.15). Mean age of seropositive blood donors were the following: women, 40 y (SD 13.73 y); men, 41.8 y (SD 13.71 y).
†French territorial division elevations: Alpes de Haute Provence, 280–3,412 m; Hautes Alpes, 430–4,101 m; Alpes Maritimes, 0–3,143 m; Bouches du Rhône, –2–1,042 m; Corsica, 0–2,706 m; Var, 0–1,714 m; Vaucluse, 12–1,909 m.

Main Article

Page created: August 08, 2011
Page updated: August 08, 2011
Page reviewed: August 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.